Scrotal Cellulitis Antibiotic Therapy
Empiric antibiotics for scrotal cellulitis (treated as nonpurulent skin and soft tissue infection) should provide activity against streptococci. [1] Antibiotic selection should include MRSA-active therapy only when MRSA risk factors or features of purulent infection are present. [1]
Pathogen Coverage Strategy
Typical cellulitis therapy should include an antibiotic active against streptococci. [1] MRSA coverage should be added for cellulitis associated with purulent drainage, penetrating trauma, or concurrent evidence of MRSA infection elsewhere. [1]
Medication Selection Algorithm
Streptococcal coverage (typical, uncomplicated cellulitis) options include: [1]
- Penicillin. [1]
- Amoxicillin. [1]
- Amoxicillin-clavulanate. [1]
- Dicloxacillin. [1]
- Cephalexin. [1]
- Clindamycin. [1]
MRSA coverage when indicated (purulence/penetrating trauma or concurrent MRSA) options include: [1]
- IV vancomycin. [1]
- IV daptomycin. [1]
- IV linezolid. [1]
- IV telavancin. [1]
- Oral doxycycline. [1]
- Oral clindamycin. [1]
- Oral trimethoprim-sulfamethoxazole (SMX-TMP). [1]
Oral regimens to cover both streptococci and MRSA include: [1]
- Clindamycin alone. [1]
- Combination therapy using one agent with MRSA coverage plus an additional agent to cover streptococci (options described in the guideline text). [1]
Treatment Duration
For uncomplicated cellulitis, a 5-day course of antimicrobial therapy is as effective as a 10-day course when clinical improvement occurs by day 5. [1]
Key Evidence and Guideline Observations
MRSA is an unusual cause of typical cellulitis, and β-lactam treatment for cellulitis has demonstrated high success rates in a prospective study context cited by the guideline. [1] Coverage for MRSA is considered prudent in cellulitis associated with penetrating trauma. [1]
Initiation Thresholds and Site-Specific Urgency
Outpatient oral therapy can be appropriate for patients without systemic inflammatory response syndrome (SIRS), altered mental status, or hemodynamic instability in the guideline framework for cellulitis severity. [1] Prompt broad empiric therapy plus emergent surgical evaluation is recommended when necrotizing fasciitis (including Fournier gangrene) is suspected. [1]
Regimens for Suspected Necrotizing Fasciitis (Including Fournier Gangrene)
Empiric antibiotic treatment for necrotizing fasciitis should be broad. [1] Examples of broad regimens in the guideline include vancomycin or linezolid plus piperacillin-tazobactam, or plus a carbapenem, or plus ceftriaxone and metronidazole. [1]
Common Pitfalls to Avoid
Using MRSA-active therapy for typical nonpurulent cellulitis without MRSA risk features is not routinely necessary because MRSA is uncommon as a cause of typical cellulitis in the guideline evidence summary. [1] Failure to include streptococcal activity for typical cellulitis is inconsistent with guideline-recommended coverage. [1]
Targets of Therapy
Clinical improvement by day 5 supports use of a 5-day course for uncomplicated cellulitis. [1]